Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Preferred Shares Issued: 2017-2019

  • Rhythm Pharmaceuticals' Preferred Shares Issued was N/A to $263,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $41.4 million, marking a year-over-year change of. This contributed to the annual value of $138.8 million for FY2024, which is N/A change from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Preferred Shares Issued stood at $263,000 for Q3 2019, which was down 10.85% from $295,000 recorded in Q1 2019.
  • Rhythm Pharmaceuticals' Preferred Shares Issued's 5-year high stood at $20.5 million during Q3 2017, with a 5-year trough of $263,000 in Q3 2019.
  • Its 2-year average for Preferred Shares Issued is $10.3 million, with a median of $10.3 million in 2017.